Vascular endothelial growth factor induces multidrug resistance-associated protein 1 overexpression through phosphatidylinositol-3-kinase/protein kinase B signaling pathway and transcription factor specificity protein 1 in BGC823 cell line

Acta Biochimica et Biophysica Sinica

Volumn 45, Issue 8, 2013, Pages 656-663

  Li, Juan ^a   Wu, Xiaojun ^a   Gong, Jinling ^a   Yang, Jing ^a   Leng, Jiayan ^a   Chen, Qiaoyun ^a   Xu, Wenlin ^a  

^a AFFILIATED PEOPLE S HOSPITAL OF JIANGSU UNIVERSITY   (China)

Author keywords

cancer; MRP1; PI3K AKT signaling pathway; SP1; VEGF

Indexed keywords

EID: 84880931435     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmt062     Document Type: Article

References (27)

1. Altenberg GA. Structure of multidrug-resistance proteins of the ATP-binding cassette (ABC) superfamily. Curr Med Chem AntiCancer Agents 2004, 4: 53-62.
2. Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC and Stewart AJ, et al. Over-expression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992, 258: 1650-1654.
3. Ghanem MA, van Steenbrugge GJ, Sudaryo MK, Mathoera RB, Nijman JM and van der Kwast TH. Expression and prognostic relevance of vascular endothelial growth factor (VEGF) and its receptor (FLT-1) in nephroblastoma. J Clin Pathol 2003, 56: 107-113.
4. Imura S, Miyake H, Izumi K, Tashiro S and Uehara H. Correlation of vascular endothelial cell proliferation with microvessel density and expression of vascular endothelial growth factor and basic fibroblast growth factor in hepatocellular carcinoma. J Med Invest 2004, 51: 202-209.
5. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS and Ferrara N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 1993, 362: 841-844.
6. Ferrara N and Henzel WJ. Pituitary follicular cells secrete a novel heparinbinding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989, 161: 851-858.
7. Inda AM, Andrini LB, Garcia MN, García AL, Fernández Blanco A, Furnus CC and Galletti SM, et al. Evaluation of angiogenesis with the expression of VEGF and CD34 in human non-small cell lung cancer. J Exp Clin Cancer Res 2007, 26: 375-378.
8. Santos SC and Dias S. Internal and external autocrine VEGF/KDR loops regulate survival of subsets of acute leukemia through distinct signaling pathways. Blood 2004, 103: 3883-3889.
9. Kubota Y, Ohnishi H, Kitanaka A, Ishida T and Tanaka T. Constitutive activation of PI3K is involved in the spontaneous proliferation of primary acute myeloid leukemia cells: direct evidence of PI3Kactivation. Leukemia 2004, 18: 1438-1440.
10. Min YH, Eom JI, Cheong JW, Maeng HO, Kim JY, Jeung HK and Lee ST, et al. Constitutive phosphorylation of Akt/PKB protein in acute myeloid leukemia: its significance as a prognosic variable. Leukemia 2003, 17: 995-997.
11. Xu Q, Simpson SE, Scialla TJ, Bagg A and Carroll M. Survival of acute myeloid leukemia cells requires PI3 kinase activation. Blood 2003, 102: 972-980.
12. Tazzari PL, Cappellini A, Ricci F, Evangelisti C, Papa V, Grafone T and Martinelli G, et al. Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blasts. Leukemia 2007, 21: 427-438.
13. Volm M and Rittgen W. Cellular predictive factors for the drug response of lung cancer. Anticancer Res 2000, 20: 3449-3458.
14. Avramis IA, Kwock R and Avramis VI. Taxotere and vincristine inhibit the secretion of the angiogenesis inducing vascular endothelial growth factor (VEGF) by wild-type and drug-resistant human leukemia cell lines. Anticancer Res 2001, 21: 2281-2286.
15. Amino N, Ideyama Y, Yamano M, Kuromitsu S, Tajinda K, Samizu K and Hisamichi H, et al. YM-359445, an orally bioavailable vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor, has highly potent antitumor activity against established tumors. Clin Cancer Res 2006, 12: 1630-1638.
16. Zhang XS, Zhu XF, Gao JS, Qian CN, Kuang ZJ, Liu ZC and Zeng YX, et al. Multiple drug resistance phenotype of human endothelial cells induced by vascular endothelial growth factor 165. Acta Pharmacol Sin 2001, 22: 731-735.
17. Zhu Q and Center MS. Cloning and sequence analysis of the promoter region of the MRP gene of HL60 cells isolated for resistance to Adriamyein. Cancer Res 1994, 54: 4488-4492.
18. Xu WL, Shen HL, Yuan W, Jiang YW, Wu ZY, Fei X and Tang HR, et al. Experimental study on the role of VEGF autocrine loop in K562 leukemia cells. Zhonghua Xue Ye Xue Za Zhi 2007, 28: 189-193.
19. Neri LM, Borgatti P, Tazzari PL, Bortul R, Cappellini A, Tabellini G and Bellacosa A, et al. The phosphoinositide3-kinase/AKT1 pathway involvement in drug and all-trans-retinoic acid resistance of leukemia cells. Mol Cancer Res 2003, 1: 234-246.
20. Rieber M and Strasberg RM. Unequal nuclear Sp1/GC box DNA binding activity distinguishes proliferating from differentiated senescent or apoptotic cells. Int J Cancer 1999, 83: 359-364.
21. Laupeze B, Amiot L, Drenou B, Bernard M, Branger B, Grosset JM and Lamy T, et al. High multidrug resistance protein activity in acute myeloid leukemias is associated with poor response to chemotherapy and reduced patient surviva. Br J Haematol 2002, 116: 834-838.
22. Calvo A, Catena R, Noble MS, Carbott D, Gil-Bazo I, Gonzalez-Moreno O and Huh JI, et al. Identification of VEGF-regulated genes associated with increased lung metastatic potential:functional involvement of tenascin-C in tumor growth and lung metastasis. Oncogene 2008, 27: 5373-5384.
23. Lieto E, Ferraraccio F, Orditura M, Castellano P, Mura AL, Pinto M and Zamboli A, et al. Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients. Ann Surg Oncol 2008, 15: 69-79.
24. Fabbro D, Ruetz S, Bodis S, Pruschy M, Csermak K, Man A and Campochiaro P, et al. PKC412-a protein kinase inhibitor with a broad therapeutic potential. Anticancer Drug Des 2000, 15: 17-28.
25. Kummoto K, Uesaka T, Kimura A, Kobayashi M, Watanabe H and Katoh O. ZK7, a novel zinc finger gene, is induced by vascular endothelial growth factor and inhibits apoptotic death in hematopoietic cells. Cancer Res 2000, 60: 425-430.
26. Abdul-Ghani R, Serra V, Gyorffy B, Jü rchott K, Solf A, Dietel M and Schäfer R, et al. The PI3K inhibitor LY294002 blocks drug export from resistant colon carcinoma cells overexpressing MRP1. Oncogene 2006, 25: 1743-1752.
27. Pore N, Liu S, Shu HK, Li B, Haas-Kogan D, Stokoe D and Milanini-Mongiat J, et al. Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism. Mol Biol Cell 2004, 15: 4841-4853.